Business Today

'Organised loot': PIL filed in Bombay HC, seeks sale of COVID-19 vaccines at Rs 150 per dose

Besides the central and state governments, Serum Institute of India (SII) and Bharat Biotech have also been made parties to the PIL

twitter-logoBusinessToday.In | April 28, 2021 | Updated 18:15 IST
'Organised loot': PIL filed in Bombay HC, seeks sale of COVID-19 vaccines at Rs 150 per dose
People wait in long queues at a COVID-19 vaccine facility in Kolkata. (PTI)

A petition seeking the sale of COVID-19 vaccines - Covaxin and Covishield at Rs 150 per dose was filed in Bombay High Court on Wednesday. The Public Interest Litigation (PIL) was moved by Mumbai-based lawyer Fayzan Khan and three law students, alleging that the pharma companies are engaged in an "organised loot" and that the court's intervention is essential to protect public health.

The PIL also seeks HC's directions to be issued to the Centre and state governments to ensure that the coronavirus vaccines are sold at a uniform rate - Rs 150 - across the country.

The petition adds that the move is required to ensure that fundamental rights to equality and life are "not left to the mercy of the pharmaceutical companies."

Also Read: Covishield cheapest COVID-19 vaccine in world: Adar Poonawalla

Besides the central and state governments, Serum Institute of India (SII) and Bharat Biotech have also been made parties to the PIL.

"Central Government, State Government should take all the steps ensuring the availability of the "COVID-19 vaccine" at a uniform rate of Rs. 150/- per dose for the citizen by exercising powers under National Disaster Management Act, 2005, Essential Commodities Act and sovereign powers to achieve the goal of complete vaccination and to protect the national public health," the PIL stated.

It stated that the vaccine is presumed to be an essential commodity and hence its management and distribution cannot be left in the hands of private companies.

"These pharma giants are milking the fear psychosis of the increased death rates due to COVID-19," it said.

Under the third phase of the national vaccination drive commencing next month, vaccine manufacturers would supply 50 per cent of their monthly Central Drugs Laboratory (CDL) released doses to the central government and would be free to supply the remaining 50 per cent doses to state governments and in the open market, the government had said.

Also Read: Explain 'rationale' behind COVID-19 vaccine pricing, action plan for May 1: SC asks Centre

"In a situation where the entire country is gripped with the COVID-19 pandemic, price control by the government is a must and such kind of loot and blackmail should not be permitted," it said.

The PIL also questioned the propriety of (the Centre) in asking state governments to compete in the open market for vaccines.

"Both the state as well as the Central government have the constitutional obligation to protect the health of a citizen and there cannot be any discrimination. Asking state governments to compete in the open market for vaccine procurement with the Centre and private hospitals is not correct," the plea said.

It further said that the cost difference would also lead to discrimination between different states.

"Experience shows that the BJP-led state governments would be supplied the vaccine by the central government but non-BJP ruling states would not be supplied and they would be forced to purchase the vaccines at a higher rate," the petitioners said.

The plea requested HC to quash and set aside the prices declared by the SII for Covishield and by the Bharat Biotech for Covaxin.

It further sought direction for vaccine rates to be fixed at a uniform rate of Rs 150 (plus GST) for all citizens.

"Combating the coronavirus is in the national interest and private entities like the Serum Institute of India should not be given any control over the health of a citizen. The Union and state governments have sovereign powers for management, control, production and equitable distribution and inoculation of the vaccine," the plea said.

The PIL further said the SII was selling the vaccines at Rs 150 (plus GST) for the Central government, Rs 400 for the state government and Rs 600 for private hospitals.

Similarly, Bharat Biotech has fixed the rate at Rs 600 for Covaxin for state governments and Rs 1200 for private hospitals.

The PIL said that initially when the vaccine administration programme was rolled out in India, the Centre held control over the usage, distribution and price of the vaccine.

"The government has now notified that from May 1, the vaccine would be available for all citizens above the age of 18. Now leaving the cost in the hands of the pharma companies is not reasonable or justified," the petition said.

The petition is likely to be mentioned before a division bench of Chief Justice Dipankar Datta and Justice G S Kulkarni seeking an urgent hearing.

(With inputs from PTI.)

  • Print
A    A   A